Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
Cellebrite DI (CLBT)
Top performer
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/21/2025: CLBT (5-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Outstanding Performance
These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.
Number of Analysts
8 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $24.29
1 Year Target Price $24.29
| 6 | Strong Buy |
| 2 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 152.17% | Avg. Invested days 90 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  5.0 |
| Profits based on simulation | Last Close 07/21/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 3.44B USD | Price to earnings Ratio - | 1Y Target Price 24.29 |
Price to earnings Ratio - | 1Y Target Price 24.29 | ||
Volume (30-day avg) 8 | Beta 1.32 | 52 Weeks Range 11.90 - 26.30 | Updated Date 07/21/2025 |
52 Weeks Range 11.90 - 26.30 | Updated Date 07/21/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.92 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -46.34% | Operating Margin (TTM) 11.41% |
Management Effectiveness
Return on Assets (TTM) 6.05% | Return on Equity (TTM) -115.35% |
Valuation
Trailing PE - | Forward PE 37.17 | Enterprise Value 3044696491 | Price to Sales(TTM) 8.22 |
Enterprise Value 3044696491 | Price to Sales(TTM) 8.22 | ||
Enterprise Value to Revenue 7.26 | Enterprise Value to EBITDA 50.94 | Shares Outstanding 239470000 | Shares Floating 106414614 |
Shares Outstanding 239470000 | Shares Floating 106414614 | ||
Percent Insiders 45.54 | Percent Institutions 47.76 |
Upturn AI SWOT
Cellebrite DI
Company Overview
History and Background
Cellebrite DI was founded in 1999 as a mobile forensics company. Initially focused on data transfer between mobile devices, it evolved into a leading provider of digital intelligence solutions for law enforcement, government agencies, and enterprises. Key milestones include the development of advanced data extraction and analysis tools.
Core Business Areas
- Digital Intelligence Solutions: Provides solutions for legally accessing and managing digital data from various sources (mobile devices, cloud, computers) to accelerate investigations. This includes data extraction, decoding, and analysis tools.
- Enterprise Investigative Solutions: Offers solutions to help businesses with internal investigations, compliance, and e-discovery processes.
- Training and Services: Provides training programs and expert services to help users effectively utilize Cellebrite's solutions.
Leadership and Structure
The leadership team consists of a CEO (currently Tal Dilian), a CFO, and other key executives responsible for various departments such as sales, marketing, and product development. The company has a global presence with offices in multiple countries and operates under a board of directors.
Top Products and Market Share
Key Offerings
- UFED (Universal Forensic Extraction Device): A leading solution for extracting data from mobile devices. Cellebrite claims a significant portion of the digital intelligence market, but precise figures are difficult to obtain due to industry fragmentation. Competitors include Magnet Forensics, Oxygen Forensics, and MSAB. Market share data is often proprietary and not readily available to the public. Estimated number of users is difficult to find, revenue from product not released.
- Cellebrite Pathfinder: An AI-powered analytics platform that helps investigators analyze large volumes of digital data. Competitors are similar to UFED and other investigation analysis tools. Market share data is often proprietary and not readily available to the public. Estimated number of users is difficult to find, revenue from product not released.
- Cellebrite Premium: Provides advanced access to iOS and Android devices. This is positioned as a premium service for bypassing device security. Competitors are other vulnerability research firms. Market share data is often proprietary and not readily available to the public. Estimated number of users is difficult to find, revenue from product not released.
Market Dynamics
Industry Overview
The digital intelligence industry is experiencing rapid growth, driven by the increasing volume and complexity of digital data. The need for effective tools to extract, analyze, and manage this data is growing across law enforcement, government agencies, and enterprises. This market is sensitive to privacy concerns and legal regulations.
Positioning
Cellebrite DI is positioned as a leader in the digital intelligence market, particularly for law enforcement. Its competitive advantages include a strong brand reputation, a comprehensive suite of solutions, and a large customer base. However, it faces competition from other players and must continually innovate to maintain its market position.
Total Addressable Market (TAM)
The TAM for the digital intelligence market is estimated to be in the billions of dollars and growing. Cellebrite is well-positioned to capture a significant portion of this TAM, given its established presence and comprehensive product offerings.
Upturn SWOT Analysis
Strengths
- Established brand reputation
- Comprehensive suite of digital intelligence solutions
- Large customer base, especially in law enforcement
- Strong focus on innovation and R&D
Weaknesses
- Dependence on government contracts
- Potential for ethical concerns related to data privacy
- Relatively high product costs
- Negative press due to ethical concerns about unlocking phones of private citizens
Opportunities
- Expanding into new markets and geographies
- Developing new solutions for enterprise customers
- Leveraging AI and machine learning to enhance its products
- Partnering with other technology companies
Threats
- Increasing competition from other digital intelligence providers
- Changing regulations and privacy laws
- Potential for data breaches or security vulnerabilities
- Public perception challenges regarding surveillance technology
Competitors and Market Share
Key Competitors
- MSAB (MSAB.ST)
- Magnet Forensics (MAGT.TO)
- Oxygen Forensics
Competitive Landscape
Cellebrite has the advantage of having a significant portion of the market share but faces pressure from competitors with competitive forensic suites. Cellebrite also receives pressures due to ethical concerns as it faces scrutiny from privacy advocates.
Major Acquisitions
BlackBag Technologies
- Year: 2020
- Acquisition Price (USD millions): 33
- Strategic Rationale: Expanded Cellebrite's capabilities in computer forensics and incident response.
Growth Trajectory and Initiatives
Historical Growth: Cellebrite's growth has been driven by the increasing demand for digital intelligence solutions from law enforcement and government agencies. Its historical growth is tied to its ability to innovate and maintain its leadership position in the market.
Future Projections: Future growth projections depend on the continued expansion of the digital intelligence market and Cellebrite's ability to capture market share. Analyst estimates (if available) would provide more specific projections.
Recent Initiatives: Recent initiatives include developing new AI-powered analytics tools, expanding its cloud-based solutions, and forming strategic partnerships with other technology companies.
Summary
Cellebrite DI is a major player in the digital intelligence market, known for its comprehensive solutions and strong presence in law enforcement. While its brand and product offerings are strengths, it faces competition and ethical concerns related to privacy. Future growth depends on innovation and its ability to navigate regulatory challenges. While well positioned, it must balance innovation with ethical considerations to sustain long-term growth.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- Industry Reports
- Analyst Reports (if available)
- Press Releases
- SEC Filings (if available)
Disclaimers:
This analysis is based on available information and estimates. Market share data is often proprietary and may not be precise. Financial information is limited due to the company's ownership structure. This is not financial advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Cellebrite DI
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2021-08-31 | CEO & Director Mr. Thomas E. Hogan | ||
Sector Technology | Industry Software - Infrastructure | Full time employees 1167 | Website https://www.cellebrite.com |
Full time employees 1167 | Website https://www.cellebrite.com | ||
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to access, collect, review, extract, decode, decrypt, analyze, share, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, organized crime, human trafficking, corporate security, cryptocurrency, and intellectual property theft. It provides Inseyets, a digital forensics software that collects and reviews digital evidence from various digital sources when conducting legally sanctioned investigations. The company's digital forensics software also offers data extraction, decoding capabilities, workflows, and automation capabilities. In addition, it provides Cellebrite Pathfinder, which reduces the time spent manually reviewing digital evidence by automating data analysis and visualization; Smart Search, an open source intelligence tool that automates the collection and review of publicly available online data; and Guardian, a case and evidence management solution. Further, the company offers digital forensic software for enterprises and service providers, including Inseyets for Enterprise, Endpoint Inspector, and Endpoint Mobile Now; and professional services, such as training and certification services, and advanced services. It serves federal and state and local agencies. The company was founded in 1999 and is headquartered in Petah Tikva, Israel.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.